Landscape Capital Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-22,347
Closed -$659K 888
2025
Q4
$659K Buy
22,347
+11,037
+98% +$300K 0.04% 436
2025
Q3
$292K Buy
+11,310
New +$315K 0.02% 519
2020
Q2
Sell
-35,161
Closed -$1.05M 495
2020
Q1
$1.05M Buy
+35,161
New +$809K 0.11% 205

Other funds holding MRNA

Landscape Capital Management's MRNA Position: Q1 2026 in Review

Landscape Capital Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 22,347 shares — an estimated $659K sold.

Landscape Capital Management first reported a position in MRNA in Q1 2020 and held it in 3 quarters. The position peaked at $1.05M in Q1 2020. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Landscape Capital Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Landscape Capital Management sold 22,347 Moderna shares in Q1 2026, an estimated $659K.
  • Landscape Capital Management first reported a position in Moderna in Q1 2020 and held it in 3 quarters.
  • Landscape Capital Management's Moderna position peaked at $1.05M in Q1 2020.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.